123 related articles for article (PubMed ID: 23905616)
1. The use of FDG-PET/CT in patients with febrile neutropenia.
Vos FJ; Bleeker-Rovers CP; Oyen WJ
Semin Nucl Med; 2013 Sep; 43(5):340-8. PubMed ID: 23905616
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation.
Vos FJ; Donnelly JP; Oyen WJ; Kullberg BJ; Bleeker-Rovers CP; Blijlevens NM
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):120-8. PubMed ID: 21947022
[TBL] [Abstract][Full Text] [Related]
3. ¹⁸F-FDG-PET/CT Imaging in Patients with Febrile Neutropenia and Haematological Malignancies.
Camus V; Edet-Sanson A; Bubenheim M; Hitzel A; Becker S; David M; Stamatoullas A; Lenain P; Jardin F; Contentin N; Fontoura ML; Cardinael N; Vaudaux S; Dubois S; Tilly H; Vera P; Leprêtre S
Anticancer Res; 2015 May; 35(5):2999-3005. PubMed ID: 25964587
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report.
Tibúrcio FR; de Sá Rodrigues KE; Vasconcelos HM; Miranda DM; Simões e Silva AC
BMC Pediatr; 2015 Sep; 15():108. PubMed ID: 26337867
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia.
Hess S
PET Clin; 2020 Apr; 15(2):175-185. PubMed ID: 32145888
[TBL] [Abstract][Full Text] [Related]
6. Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients.
Guy SD; Tramontana AR; Worth LJ; Lau E; Hicks RJ; Seymour JF; Thursky KA; Slavin MA
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1348-55. PubMed ID: 22584486
[TBL] [Abstract][Full Text] [Related]
7. [18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin.
Gafter-Gvili A; Raibman S; Grossman A; Avni T; Paul M; Leibovici L; Tadmor B; Groshar D; Bernstine H
QJM; 2015 Apr; 108(4):289-98. PubMed ID: 25208896
[TBL] [Abstract][Full Text] [Related]
8. The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia.
Gafter-Gvili A; Paul M; Bernstine H; Vidal L; Ram R; Raanani P; Yeshurun M; Tadmor B; Leibovici L; Shpilberg O; Groshar D
Leuk Res; 2013 Sep; 37(9):1057-62. PubMed ID: 23849986
[TBL] [Abstract][Full Text] [Related]
9. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
10. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.
Kluge S; Braune S; Nierhaus A; Wichmann D; Derlin T; Mester J; Klutmann S
J Crit Care; 2012 Jun; 27(3):316.e1-7. PubMed ID: 22176803
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
[TBL] [Abstract][Full Text] [Related]
15. F-18 FDG PET/CT in the diagnosis of fever of unknown origin.
Balink H; Collins J; Bruyn GA; Gemmel F
Clin Nucl Med; 2009 Dec; 34(12):862-8. PubMed ID: 20139818
[TBL] [Abstract][Full Text] [Related]
16. Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia.
Koh KC; Slavin MA; Thursky KA; Lau E; Hicks RJ; Drummond E; Wong PS; Worth LJ
Leuk Lymphoma; 2012 Oct; 53(10):1889-95. PubMed ID: 22448920
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.
Cautela J; Alessandrini S; Cammilleri S; Giorgi R; Richet H; Casalta JP; Habib G; Raoult D; Mundler O; Deharo JC
Europace; 2013 Feb; 15(2):252-7. PubMed ID: 23148119
[TBL] [Abstract][Full Text] [Related]
18. Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases.
Revest M; Patrat-Delon S; Devillers A; Tattevin P; Michelet C
Med Mal Infect; 2014 Jun; 44(6):251-60. PubMed ID: 24844599
[TBL] [Abstract][Full Text] [Related]
19. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.
Shejul Y; Chhajed PN; Basu S
J Nucl Med Technol; 2014 Sep; 42(3):235-7. PubMed ID: 24948823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
